Meti, N.; Tahmasebi, H.; Leahey, A.; Boudreau, A.; Thawer, A.; Stewart, J.; Reason, P.; Albright, K.; Leis, J.A.; Katz, K.;
et al. SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience. Curr. Oncol. 2021, 28, 278-282.
https://doi.org/10.3390/curroncol28010032
AMA Style
Meti N, Tahmasebi H, Leahey A, Boudreau A, Thawer A, Stewart J, Reason P, Albright K, Leis JA, Katz K,
et al. SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience. Current Oncology. 2021; 28(1):278-282.
https://doi.org/10.3390/curroncol28010032
Chicago/Turabian Style
Meti, Nicholas, Houman Tahmasebi, Angela Leahey, Angela Boudreau, Alia Thawer, Janice Stewart, Paige Reason, Kirsty Albright, Jerome A. Leis, Kevin Katz,
and et al. 2021. "SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience" Current Oncology 28, no. 1: 278-282.
https://doi.org/10.3390/curroncol28010032
APA Style
Meti, N., Tahmasebi, H., Leahey, A., Boudreau, A., Thawer, A., Stewart, J., Reason, P., Albright, K., Leis, J. A., Katz, K., Cheung, M. C., & Singh, S.
(2021). SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience. Current Oncology, 28(1), 278-282.
https://doi.org/10.3390/curroncol28010032
